Ranbaxy may dilute 60% in new R&D unit
Ranbaxy Laboratories may dilute up to 60% stake in its new research company, which will be formed by hiving off its R&D unit into a separate entity in 2008.
Ranbaxy Laboratories may dilute up to 60% stake in its new research company, which will be formed by hiving off its R&D unit into a separate entity in 2008.
Nicholas Piramal (NPIL) has reportedly signed a research deal potentially worth a maximum revenue of USD 350 million with US pharmaceutical giant Merck & Co to carry out early discovery and development of two new cancer drugs, the two companies said on Monday.
UK-listed healthcare services BPO firm CBaySystems has announced the acquisition of Nagpur-based medical transcription services provider Suyash Software in a cash and stock deal.
The Shroff Eye Hospital in Mumbai recently launched the worlds safest and fastest eye laser, using the Wavelight Concerto 500 Hz Laser system designed to occupy a novel niche market of luxury excimer laser technology.
The Federal Communications Commission (FCC) has launched US$ 400 million program under which patients in rural areas would be able to tap the nation’s top doctors over the Internet.
Seeking to expand Indo-U.S. healthcare cooperation, the U.S.-India Business Council’s (USIBC) ‘Coalition for Healthy India’ launched its inaugural utive mission to India.
Symantec Corp. has announced the Symantec Healthcare Provider Solution, a new solution, comprised of products, services and best practices to help healthcare providers protect and manage their critical infrastructure and ensure vital patient information is both protected and accessible.
India has introduced a medical visa aimed at assisting overseas visitors to travel to the country for low-cost hospital treatment.
Apollo Health Street (AHS), the healthcare business process outsourcing subsidiary of Apollo Group that runs India
Clinical research firm Manipal AcuNova Ltd recently announced it has completed the acquisition of ECRON GmbH, Europe.
The LORENZ Life Sciences Group announced recently that Orchid Chemicals & Pharmaceuticals, located in Chennai, India has chosen docuBridge as its eCTD Publishing and Management solution.
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country